CATALOGO DEI PRODOTTI DELLA RICERCA

PERBELLINI, Omar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.595
EU - Europa 3.738
AS - Asia 2.563
SA - Sud America 296
AF - Africa 23
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.235
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.522
GB - Regno Unito 1.312
CN - Cina 1.147
SG - Singapore 844
DE - Germania 560
SE - Svezia 390
FI - Finlandia 280
FR - Francia 261
HK - Hong Kong 258
IT - Italia 256
BR - Brasile 248
IE - Irlanda 238
RU - Federazione Russa 211
VN - Vietnam 63
UA - Ucraina 59
KR - Corea 50
CA - Canada 49
NL - Olanda 45
BE - Belgio 40
TR - Turchia 35
IN - India 32
JP - Giappone 28
MX - Messico 19
ID - Indonesia 17
PL - Polonia 15
ES - Italia 14
IR - Iran 14
AR - Argentina 13
BD - Bangladesh 13
AU - Australia 12
UZ - Uzbekistan 11
ZA - Sudafrica 10
AT - Austria 9
EC - Ecuador 8
CL - Cile 7
NP - Nepal 7
RO - Romania 7
IQ - Iraq 6
KZ - Kazakistan 6
PE - Perù 6
HU - Ungheria 5
VE - Venezuela 5
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
CZ - Repubblica Ceca 4
GR - Grecia 4
IL - Israele 4
LT - Lituania 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
MA - Marocco 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
TG - Togo 2
BJ - Benin 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MY - Malesia 1
NE - Niger 1
NG - Nigeria 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
YE - Yemen 1
Totale 11.235
Salva come PNG Salva come JPEG
Città #
Southend 1.149
Chandler 584
Dallas 511
Jacksonville 456
Woodbridge 421
Singapore 404
Ann Arbor 397
Ashburn 292
Beijing 256
Hong Kong 253
Dublin 238
Munich 202
New York 148
Wilmington 125
Houston 121
Jinan 95
Helsinki 88
Lawrence 87
Princeton 87
Nanjing 80
Verona 69
The Dalles 67
Shenyang 65
Los Angeles 63
Tianjin 50
Hebei 45
Turku 42
Buffalo 41
Falls Church 40
Brussels 38
Columbus 38
Haikou 35
Hangzhou 33
Ningbo 33
Nanchang 31
Zhengzhou 31
Boardman 30
Changsha 29
Guangzhou 28
Seoul 28
Norwalk 24
Tokyo 23
Taiyuan 22
Groningen 21
Milan 21
São Paulo 21
Hanoi 20
Redondo Beach 20
Sindelfingen 20
Taizhou 20
Dearborn 17
Jiaxing 17
Santa Clara 17
Chicago 16
Düsseldorf 16
Nürnberg 16
Fuzhou 15
Manchester 15
Stockholm 15
Frankfurt am Main 14
Montreal 14
Seattle 14
Dong Ket 13
Lanzhou 13
Bologna 12
Redmond 12
Ho Chi Minh City 11
Jakarta 11
Kent 11
Redwood City 11
Amsterdam 10
Brooklyn 10
San Francisco 10
Tashkent 10
Toronto 10
Washington 10
Boston 9
Johannesburg 9
Moscow 9
Warsaw 9
Council Bluffs 8
Lancaster 8
San Mateo 8
Auburn Hills 7
Augusta 7
Belo Horizonte 7
Padova 7
Ardabil 6
Chennai 6
Châtenay-Malabry 6
Enterprise 6
Leawood 6
Lima 6
London 6
Mestre 6
Nuremberg 6
Paris 6
Qingdao 6
Vienna 6
Atlanta 5
Totale 7.547
Salva come PNG Salva come JPEG
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 391
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 261
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 189
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 188
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 187
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 176
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 175
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 171
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 170
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 168
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 167
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 162
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 161
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 160
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 159
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 155
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 155
BCR-signaling profiles associated with prognosis and progression in B-CLL 152
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 152
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 150
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 150
A quantitative study on the growth variability of tumour cell clones in vitro 148
BCR-signaling profiles associated with prognosis and progression in B-CLL 148
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 147
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 142
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 141
Characterization of the cross-talk between human neutrophils and a subset of pro-inflammatory dendritic cells 139
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 139
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 135
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 135
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 134
Underdiagnosed systemic mastocytosis: The role of flow cytometry 133
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 132
SIGNALING NETWORK IN T-CELL LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A SINGLE-CELL MULTI-PARAMETRIC PHOSPHO-FLOW CYTOMETRY STUDY 130
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 127
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 126
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 126
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 125
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 124
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 124
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia 123
Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction 121
Cross-talks within the innate immune system: the role of neutrophils 120
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 120
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 120
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 119
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 119
Human Bone marrow Mesenchymal Stem Cells protect B-cell Acute Lymphoblastic Leukemia from apoptosis in vitro by upregulation of Notch3 and Notch4 on both cell types 118
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 118
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 118
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 118
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 117
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 116
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 115
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 114
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 113
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 112
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 112
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 111
Adult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid associated antigens. 109
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 107
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 106
High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas. 106
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 105
On the potential involvement of CD11d in co-stimulating the production of interferon-{gamma} by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3 104
Notch-3 and Notch-4 signaling rescues from apoptosis Human B-lineage Acute Lymphoblastic Leukemia cells in contact with Human Bone marrow-derived Mesenchymal Stromal Cells 100
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 99
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia 98
Neutrophil activation and survival are modulated by interaction with NK cells 98
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 97
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 94
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 93
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL 91
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 90
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases 89
Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia 88
IDENTIFICATION AND CHARACTERIZATION OF CANDIDATE MYELOID DERIVED SUP- PRESSOR CELLS IN THE MONONUCLEAR FRACTION OF PERIPHERAL BLOOD SAMPLES FROM PATIENTS AFFECTED BY NON-HODGKIN LYMPHOMA (NHL), HODGKIN LYMPHOMA (HL), AND MULTIPLE MYELOMA (MM) 88
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells 87
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 85
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 82
On the co-purification of 6-sulfo LacNAc(+) dendritic cells (slanDC) with NK cells enriched from human blood. 79
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 77
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 75
null 70
Multi-parametric phospho-flow cytometry in T-call Acute Lymphoblastic Leukemia 69
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 69
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 68
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 68
null 55
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 52
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 48
Totale 11.324
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.064
article - articoli 19.401
book - libri 0
conference - conferenze 18.663
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021617 0 0 0 110 96 95 13 49 33 13 172 36
2021/2022872 86 257 5 83 68 33 20 48 40 23 60 149
2022/20231.667 103 192 134 320 135 403 17 99 206 13 33 12
2023/2024938 51 72 55 76 102 209 60 66 7 47 126 67
2024/20252.148 95 149 85 342 64 95 146 100 359 127 208 378
2025/20261.372 441 385 488 58 0 0 0 0 0 0 0 0
Totale 11.324